CSL opens Australian biomanufacturing facility
As the centrepiece of a $250m expansion in Australia, CSL Limited is opening a biotech manufacturing facility in Broadmeadows, Australia.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs